#USA #Veeva Systems #Boston #biotech companies #Veeva Basics

Veeva Basics: Revolutionizing Biotech Operations

In an era increasingly defined by complexity and competitiveness, Veeva Systems has emerged as a game-changer for the biotechnology industry. Recently, the company announced that more than 100 emerging biotech firms have prioritized Veeva Basics as their chosen solution to streamline and standardize their operations. This marks a significant milestone, illustrating the growing reliance on integrated technological frameworks in the clinical, regulatory, and quality domains.

The adoption of Veeva Basics reflects a trend among biotechnology companies in both the United States and Europe, where the implementation of this straightforward, adaptable solution supports companies' evolving needs. By providing pre-configured and pre-validated best-in-class applications, Veeva Basics facilitates rapid deployment, ensuring that even smaller biotech companies can benefit from sophisticated operational efficiencies.

Built on the robust Vault platform, Veeva Basics offers businesses the flexibility to scale up operations seamlessly, transitioning to a fully integrated Vault solution without the need for complex migrations. This capability provides clients with the technology and support needed to establish effective processes in core operational areas, both today and in the future.

Industry Support and Feedback

Highlighting its impact, Steve Harper, the General Manager of Veeva Basics, noted that over 100 biopharma leaders gathered at the Veeva Research, Development, and Quality Summit in Boston. This event allowed industry professionals to exchange insights, fostering future advancements in Veeva Basics. Harper emphasized the company's commitment to constantly innovating, with plans to introduce new applications that can be swiftly implemented to bolster new drug development.

To address commercial and quality control needs, Veeva Basics is set to launch two new applications:

1. Veeva LIMS Basics: Designed for virtual companies, this application will oversee contract manufacturing organizations, including batch release and Certificate of Analysis (CoA) capabilities. A stability feature is also on the horizon, expected to debut in 2026.

2. Veeva PromoMats Basics: This will encompass comprehensive lifecycle management for content, covering approval processes, storage, distribution of promotional content, and complaint management.

Both Veeva LIMS and PromoMats Basics are anticipated to launch at the beginning of 2026. Using the tried-and-true Vault platform means that clients can continue to evolve their tech infrastructure as they grow, ensuring long-term productivity and efficiency.

Testimonials from Biotechnology Firms

The impact of Veeva Basics on its users is backed by glowing testimonials from industry leaders. Richard Tornai, Senior Director of IT at Structure Therapeutics, underscored the importance of Veeva Basics in their rapid growth, stating that it enables them to standardize processes built around industry best practices. The agility provided by the platform ensures readiness for future demands without compromising on current capabilities.

Bryan Ball, Technical Operations Director at Whitehawk Therapeutics, echoed these sentiments, emphasizing that establishing a reliable quality and regulatory operations foundation was pivotal. He highlighted Veeva Basics’ compliant and cost-effective document and record management capabilities, describing them as logically structured with easily accessible libraries of templates and straightforward training.

Bernhard Irlinger, Quality Lead at AiCuris, also praised Veeva Basics for providing a top-tier solution paired with global support, which has allowed for rapid upskilling of their staff. He recognized Veeva's commitment to innovation in biotechnology as a key characteristic that makes them a valuable partner in the industry.

About Veeva Systems

Veeva Systems is renowned for supplying the life sciences sector with cloud-based software, data, and consulting services. Dedicated to innovation and excellence, Veeva serves the needs of over 1,500 clients, ranging from some of the largest global biopharmaceutical enterprises to emerging biotech companies. Veeva is committed to balancing the interests of its various stakeholders, including customers, employees, shareholders, and the industries it serves. For more information about Veeva, visit veeva.com/eu.

In summary, the widespread adoption of Veeva Basics demonstrates its significant role in streamlining biotech operations. With the continuous innovation and the introduction of new applications, Veeva Systems is poised to help the biotech industry evolve and thrive amidst its ongoing challenges.